For instance, PREDICT uses ERBB2 (formerly HER2 or HER2/neu) status, estrogen receptor status, and tumor size; the prostate cancer nomograms require knowledge of prostate-specific antigen levels, biopsy cores, or pathology reports. This evidence concerns the gene KLK3 and prostate carcinoma.